PF-Atlas › Clinical Trials › NCT02143687

Patients With Pulmonary Hypertension or Interstitial Lung Disease at Altitude - Effect of Oxygen on Exercise Performance

Moderate altitude sojourn · Phase 4

Registry ID
NCT02143687
Phase
Phase 4
Status
Completed
Drug / intervention
Moderate altitude sojourn
Sponsor
University of Zurich
Start
2014-05
Enrollment
30
Locations
1

About this trial

The purpose of this study is to investigate the effect of travelling to moderate altitude and of nocturnal oxygen therapy during a stay at moderate altitude on exercise performance of patients with pulmonary hypertension or with interstitial lung disease.

View NCT02143687 on ClinicalTrials.gov →

Explore related

All Moderate altitude sojourn trialsAll IPF trials
Medical disclaimer. This page summarizes public trial data for NCT02143687 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.